Parabilis Medicines, Inc. (PBLS)

Parabilis Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	-0.09	-0.11	-0.17
Debt / EBITDA Ratio	-0.25	-0.32	-0.40
Debt / FCF Ratio	-0.38	-0.47	-0.63
Net Debt / Equity Ratio	0.48	-0.06	0.06
Net Debt / EBITDA Ratio	1.31	-0.17	0.13
Net Debt / FCF Ratio	1.98	-0.25	0.21
Quick Ratio	6.07	0.49	2.73
Return on Equity (ROE)	26.81%	27.71%	30.71%
Return on Assets (ROA)	-	-180.51%	-79.00%
Return on Capital Employed (ROCE)	392.42%	-785.70%	-142.42%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).